CGC Genetics this week introduced a microarray panel to complement clinical diagnosis of cases where there is evidence of syndromic and nonsyndromic congenital deafness.
According to the firm, the test identifies the most frequent genetic alterations, which include 312 point mutations in 32 genes, involved in congenital hearing loss.
CGC's assay is run on the Illumina BeadXpress system.
EMD Millipore this week introduced a kit for bisulfite conversion, the first step in mapping the differences in genomic DNA methylation patterns.
The CpGenome Turbo Kit converts unmethylated cytosines to uracil in 90 minutes, which EMD Millipore claims is twice as fast as commonly used bisulfite kits and reagents.
The kit features a conversion reagent that reduces incubation times while retaining high efficiency, converting almost all unmethylated cytosines to uracil, according to the firm.
The resulting modified DNA is ready for epigenetic mapping by sequencing, microarray hybridization, or quantitative PCR.